RomanGroisbergMD

Oncology • New Brunswick, NJ

Physician

Join to view full profile

Dr. Groisberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Groisberg's full profile

Already have an account?

Office
195 Little Albany St
New Brunswick, NJ 08901
Phone+1 732-235-2465

Fax+1 732-235-6797

Education & Training

University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
Yale-New Haven Medical CenterResidency, Internal Medicine, 2012 - 2015
Tulane University School of MedicineClass of 2012

Certifications & Licensure

NJ State Medical License 2018 - 2025
TX State Medical License 2015 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Evolution of Rapid Clonal Dynamics and Non-Cross-Resistance in Response to Alternating Targeted Therapy and Chemotherapy in BRAF-V600E-Mutant Colon Cancer.
Srilatha Simhadri, Jillian N Carrick, Susan Murphy, Om A Kothari, Husam Al-Hraishami
JCO Precision Oncology. 2024-12-01
Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple-negative breast cancer: Results from the triple-negative breast cancer cohort of t...
Hyun Cheol Chung, Esma Saada-Bouzid, Federico Longo, Eduardo Yanez, Seock-Ah Im
Cancer. 2024-10-01
1 citations
Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study.
Antonio González-Martín, Hyun Cheol Chung, Esma Saada-Bouzid, Eduardo Yanez, Helene Senellart
Gynecologic Oncology. 2024-07-01

Lectures

Outcomes of patients with gene fusion driven cancers treated on early phase clinical trials.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

New Brunswick Cancer Survivor Excited for Construction of New HospitalJune 25th, 2021